Moderna COVID-19 vaccine second to get FDA sign-off in US
The Food and Drug Administration authorized the COVID-19 vaccine developed by Moderna, which joins the Pfizer and BioNTech product as the second shot available for use in the United States.
The vaccine can now be given to adults 18 years of age and older in the US. It was 94 percent effective against symptomatic COVID-19 in clinical trials. The Moderna vaccine also protects against cases of severe disease: there were 30 cases of severe disease among trial participants, and all were in the placebo group. Initial data on the Pfizer and BioNTech vaccine also indicated that it could protect against severe disease, but data was too limited to reach a definite conclusion.
“With the availability of two vaccines now for the prevention of…